Latest News

We believe that patients can lead the change in the healthcare system for the first time. We also believe that empowered patients should have a large-scale patient-centred solution that provides evidence-based product recommendations and allows them to collect their own data. This is where the Reformulary Group comes in: Cannabis Standard is one-part formulary and one-part research platform. Our vision is “smart drug and medical cannabis choices” where one day every consumer will rely on our evidence-based tools to make smart choices.

News

Canada has two systems for cannabis use, but they’re at risk of blending into one
A gap between recreational convenience and medical accessibility is shaping
Read more

News

Cannabis Standard Insights
Issue #3, featuring articles about the relaunch of Reformulary's Cannabis..
Read more

News

Cannabis Standard Index brings much-needed clarity to medical cannabis
An innovative, independent and evidence-based index of medical cannabis...
Read more

Newsletter

Cannabis Standard Insights
Issue #2, featuring articles about workplace drug tests for THC, ...
Download Newsletter

Newsletter

Cannabis Standard Insights
Reformulary Group launches its Cannabis Standard Insights newsletter.
Download Newsletter

News

Spectrum Cannabis joins Cannabis Standard - the evidence-based medical cannabis formulary for consum...
NEWSWIRE
Read more

News

Starseed joins Cannabis Standard™ for Canadians, employers, physicians
GLOBENEWSWIRE
Read more

News

Reformulary Group signs MedReleaf as first Licensed Producer for new medical cannabis formulary
GLOBENEWSWIRE
Read more

News

Expert group to review evidence for use of medical cannabis for employer plans
GLOBENEWSWIRE
Read more